tiprankstipranks
Exact Sciences Corp. (EXAS)
NASDAQ:EXAS

Exact Sciences (EXAS) Financial Statements

2,920 Followers

Exact Sciences Financial Overview

Exact Sciences's market cap is currently ―. The company's EPS TTM is $-1.135; its P/E ratio is -53.70; Exact Sciences is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.47. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 646.88M$ 628.34M$ 622.09M$ 602.45M-
Gross Profit$ 475.02M$ 459.81M$ 465.10M$ 445.58M-
EBIT$ -42.51M$ 8.91M$ -72.10M$ -72.49M-
EBITDA$ 11.65M$ 61.21M$ -23.45M$ -20.98M-
Net Income Common Stockholders$ -49.78M$ 843.00K$ -81.02M$ -74.19M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 777.64M$ 734.41M$ 775.71M$ 698.65M$ 632.06M
Total Assets$ 6.47B$ 6.42B$ 6.36B$ 6.30B$ 6.23B
Total Debt$ 2.55B$ 2.56B$ 2.56B$ 2.56B$ 2.45B
Net Debt$ 1.78B$ 1.83B$ 1.78B$ 1.87B$ 1.81B
Total Liabilities$ 3.33B$ 3.30B$ 3.30B$ 3.25B$ 3.18B
Stockholders Equity$ 3.15B$ 3.12B$ 3.06B$ 3.06B$ 3.04B
Cash Flow-
Free Cash Flow$ 34.63M$ -5.49M$ 61.44M$ -58.65M-
Operating Cash Flow$ 69.55M$ 19.70M$ 96.16M$ -29.29M-
Investing Cash Flow$ -66.77M$ -28.28M$ 70.72M$ 74.00M-
Financing Cash Flow$ 10.04M$ 92.00K$ 16.04M$ 133.60M-
Currency in USD

Exact Sciences Earnings and Revenue History

Exact Sciences Debt to Assets

Exact Sciences Cash Flow

Exact Sciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis